Aspirin for everyone older than 50? Against.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 15961819.
- Also identified by PMC identifier 558386.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Current population screening for vascular disease is neither efficient nor effective. Peter Elwood and colleagues believe we should have a public information strategy highlighting the benefits (and risks) of aspirin for older people, but Colin Baigent argues that the evidence of benefit is not yet strong enough
Medical subject headings
- Aspirin
- Fibrinolytic Agents
- Gastrointestinal Hemorrhage
- Myocardial Infarction